Methotrexate Use and Risk of Interstitial Lung Disease in Dermatomyositis

JAMA Dermatol. 2024 Jun 1;160(6):676-678. doi: 10.1001/jamadermatol.2024.0785.
No abstract available

Plain language summary

This cohort study examines the association between methotrexate use and interstitial lung disease in patients with dermatomyositis.

MeSH terms

  • Adult
  • Aged
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / adverse effects
  • Dermatomyositis* / chemically induced
  • Dermatomyositis* / diagnosis
  • Dermatomyositis* / drug therapy
  • Female
  • Humans
  • Lung Diseases, Interstitial* / chemically induced
  • Lung Diseases, Interstitial* / diagnosis
  • Lung Diseases, Interstitial* / drug therapy
  • Male
  • Methotrexate* / administration & dosage
  • Methotrexate* / adverse effects
  • Middle Aged
  • Risk Factors

Substances

  • Methotrexate
  • Dermatologic Agents